ASML’s Valuation Faces a Dual Challenge
18.12.2025 - 09:00:05Asml NL0010273215
The investment narrative surrounding ASML, the Dutch semiconductor equipment giant, is encountering new headwinds. Following a period of strong performance, the company now contends with pressure from two fronts: emerging technological competition from China and investor scrutiny over its premium stock valuation. This has prompted a more critical examination of whether its extreme ultraviolet (EUV) lithography monopoly is as impregnable as once believed.
Alongside geopolitical developments, fundamental questions about ASML's price are coming to the fore. A recent discounted cash flow (DCF) analysis suggests the shares are trading significantly above their calculated intrinsic value.
- Calculated Fair Value: Approximately $777 per share.
- Current Premium: The present share price sits about 38.5% above this fair value estimate.
- P/E Comparison: ASML trades at a price-to-earnings ratio in the range of 34 to 41. This exceeds Nvidia's P/E of around 23, despite the U.S. chip designer currently posting higher growth rates.
This combination of a substantial premium and a valuation loftier than that of a fast-growing AI leader like Nvidia leaves the equity vulnerable to corrections. Historical market patterns show that when doubts emerge about a company's technological uniqueness alongside such rich valuations, sentiment can shift rapidly.
Reports of Chinese Progress Rattle Confidence
Significant market unease stems from fresh reports concerning China's technological catch-up efforts. Market speculation indicates that a Chinese research team has developed a working prototype of an EUV lithography machine. While this apparatus is not yet producing functional chips and any potential mass production is not projected before 2028, the news strikes at the heart of the ASML investment thesis.
The company's de facto monopoly in EUV technology has been a cornerstone of its value. Previously, its technological lead was often estimated at about a decade. Investors now fear this gap could narrow faster than anticipated, especially considering the strategic importance of the Asian market and existing export control discussions. Merely the existence of an early-stage prototype alters the long-term risk perception, making the scenario of ASML facing no competition in EUV for many years appear less certain.
Selling Pressure Emerges After Strong Run
The stock has faced notable selling pressure in recent sessions, building on a significant intraday decline observed on December 17. The triggers were weaker prices across the broader AI and semiconductor sector, exacerbated by company-specific news regarding potential competition.
A notable detail: trading volume during the decline was roughly 28% above the average daily volume. Market observers interpret this as evidence of increased selling by institutional investors, rather than just profit-taking by retail participants. The share price closed recently at €865.20, placing it about 11% below its latest 52-week high, though it remains in positive territory over a twelve-month horizon.
Should investors sell immediately? Or is it worth buying Asml?
Technically, the short-term chart picture has weakened. The price is currently below its 50-day moving average but remains well above the 200-day line—a pattern typical of a correction within a longer-term uptrend. The Relative Strength Index (RSI) reading of 46 indicates a market that is neither overbought nor oversold.
Analyst Sentiment Remains Cautious
The prevailing market doubts are not being countered by strong bullish voices from the analyst community. Barclays reaffirmed its neutral stance on ASML on December 17. Bernstein also maintains a neutral rating. Both institutions see limited near-term upside potential, a view consistent with the ongoing valuation debate and geopolitical risks.
A clear shift in sentiment, in the form of widespread upgrades or materially higher price targets, has yet to materialize. This reinforces the impression that while many professional investors still believe in ASML's strong market position, they find it difficult to justify aggressive positioning at current price levels.
Operational Performance Stays Robust
From an operational standpoint, ASML continues to deliver solid financial results. The company reported third-quarter earnings per share of $6.41 on revenue of $8.8 billion. Demand for its high-end lithography systems remains robust, driven by AI data center investment and advanced chip manufacturing.
However, the market is currently largely looking past these backward-looking metrics. The focus has shifted to the long-term stability of ASML's quasi-monopoly in EUV and whether the current valuation adequately accounts for these new uncertainties.
A tension has thus emerged in the near term: a robust operational foundation on one side, contrasted with a mix of high valuation, emerging competitive perspectives from China, and recent pronounced selling pressure on the other. The coming months will likely be decisive for ASML's ability to dispel concerns about a narrowing technological lead through strong order bookings, continued innovation, and clear communication.
Ad
Asml Stock: Buy or Sell?! New Asml Analysis from December 18 delivers the answer:
The latest Asml figures speak for themselves: Urgent action needed for Asml investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 18.
Asml: Buy or sell? Read more here...


